Indianapolis, IN, United States of America

Jeffrey T Fayerman


Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 1983-1997

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey T. Fayerman

Introduction

Jeffrey T. Fayerman is a notable inventor based in Indianapolis, IN, who has made significant contributions to the field of biotechnology. With a total of 11 patents to his name, Fayerman's work primarily focuses on genetic engineering and the development of novel vectors for gene transfer.

Latest Patents

Fayerman's latest patents include groundbreaking inventions such as DNA sequences encoding porcine pancreatic carboxypeptidase B and methods for transforming Streptomyces and other actinomycetes. His work on vectors comprising the DNA and host cells transformed with these vectors is particularly noteworthy, as it facilitates the production of porcine carboxypeptidase B. Additionally, he has developed novel vectors and methods for a single-stranded DNA-mediated gene transfer system, which enhances the efficiency of gene transfer into highly restrictive host cell systems. These innovations also allow for the cloning of genes aimed at increasing the yields of known antibiotics and producing new antibiotics, antibiotic derivatives, or other useful gene products.

Career Highlights

Fayerman is currently employed at Eli Lilly and Company, where he continues to push the boundaries of biotechnological research. His extensive experience and innovative mindset have positioned him as a key player in the development of new therapeutic solutions.

Collaborations

Throughout his career, Fayerman has collaborated with esteemed colleagues such as Mark A. Richardson and Nancy E. Malin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jeffrey T. Fayerman's contributions to biotechnology through his patents and collaborative efforts exemplify the spirit of innovation in the field. His work continues to pave the way for advancements in genetic engineering and antibiotic production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…